The optimal first-line chemotherapy for ovarian carcinosarcoma has not yet been determined. We therefore sought to determine the progression-free survival (PFS) and overall survival (OS) for patients with ovarian carcinosarcoma treated at our institution with different first-line chemotherapy regimens. | Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma A single institution case series and review of the literature